Page last updated: 2024-09-02

morpholinoanthracycline mx2 and Hodgkin Disease

morpholinoanthracycline mx2 has been researched along with Hodgkin Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kuraishi, Y; Ogawa, M; Okabe, K; Sampi, K; Takemoto, Y; Tamura, K1
Fukutani, H; Hirano, A; Horikoshi, N; Inoue, K; Mizunuma, N; Mukaiyama, T; Nagamine, D; Ogawa, M; Shinagawa, K; Tabata, M1

Trials

1 trial(s) available for morpholinoanthracycline mx2 and Hodgkin Disease

ArticleYear
[Phase II study of KRN8602 (MX2) for malignant lymphoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:7

    Topics: Anorexia; Antibiotics, Antineoplastic; Carubicin; Drug Administration Schedule; Hodgkin Disease; Humans; Leukopenia; Lymphoma, Non-Hodgkin; Nausea; Thrombocytopenia; Vomiting

1998

Other Studies

1 other study(ies) available for morpholinoanthracycline mx2 and Hodgkin Disease

ArticleYear
[Phase I and pharmacokinetic study of KRN8602, a new morpholino anthracycline].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:7

    Topics: Aged; Antibiotics, Antineoplastic; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carubicin; Drug Evaluation; Female; Hodgkin Disease; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Thrombocytopenia

1989